Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
about
Immunity to Infections after Haploidentical Hematopoietic Stem Cell TransplantationAntifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsInfluence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection.Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.Invasive aspergillosis before HCT: safe to proceed?High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies.Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants.Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy.Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience.Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
P2860
Q28079606-0D9A909F-B04E-4BD3-AA8E-C370F7B49BE4Q28080147-B8C8D71B-102F-4286-A02E-C6008E3260EFQ35821259-6A81A11C-ED8F-47BB-B4EE-3584B94BD554Q36406975-4A1F0110-BDA3-4233-B7B3-D2A50F44545CQ37280740-6A7760A9-42A7-4CA0-BD2A-E39A02C92418Q37711537-23CEB29E-CFAF-47C3-BF5F-C6E040872EE9Q38261282-90F180A1-5335-4B21-8B22-342670B94173Q38284455-41F55F99-D267-42D5-A627-260276B92B8FQ38751500-4C0FBA71-409D-4E17-B50B-56C33F6C5357Q38848582-1D1EF9A8-3313-40DF-A96F-DE6EEA12EA66Q39035934-450286F3-6DAF-4B60-A18B-2DED0B9D29F0Q39048531-ABC043CB-23C0-45F2-AEA9-0DBAF4189C23Q39196770-97FEBBF8-CF4B-4EE2-8B4A-23F90CD40E98Q39196802-A7E917F0-07EC-46D0-ACD1-65A663D89C59Q39247468-141331E1-69EC-4D8C-9BD5-8BE911267FF2Q40067975-8256B2CF-0727-44B3-A3F7-6CC431820B90Q40194039-A6123C75-C18E-4F6C-BF64-D1846D5F71A2Q40357629-F3B6F139-7EF2-4F45-82A3-F4DA9D033D7FQ40515140-EE82D16A-F484-4E0F-8148-600EF95E0561Q40650174-89BDFC4A-BF72-4F4E-A568-EEAD4AF10974Q40874890-41988C09-3517-48D2-A3AB-FA63844D3D36Q41461503-865FB9A0-12E6-4C61-900B-7FC676850AB5Q41479520-6738299C-BFAE-4849-9BA4-36053B3025D4Q41703672-F50118B7-24F0-4CD2-BF05-CCA956B66FCBQ47137561-F19A33B5-E3C9-4F2E-A0D0-D4CE63CE6EE0Q47205373-31952391-2EAF-4FF6-B2C6-9950553A7636Q50072321-E9568218-782A-4A34-9601-C318B2A79390Q51047839-2BC975E0-8658-4EFC-9CAB-1A1DE729D9B3
P2860
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Incidence and outcome of invas ...... apianto Midollo Osseo (GITMO).
@en
Incidence and outcome of invas ...... aliano Trapianto Midollo Osseo
@nl
type
label
Incidence and outcome of invas ...... apianto Midollo Osseo (GITMO).
@en
Incidence and outcome of invas ...... aliano Trapianto Midollo Osseo
@nl
prefLabel
Incidence and outcome of invas ...... apianto Midollo Osseo (GITMO).
@en
Incidence and outcome of invas ...... aliano Trapianto Midollo Osseo
@nl
P2093
P50
P1476
Incidence and outcome of invas ...... rapianto Midollo Osseo (GITMO)
@en
P2093
Adriana Vacca
Alessandra Algarotti
Alessandro Bonini
Alessandro Rambaldi
Alfonso Piciocchi
Andrea Bacigalupo
Angelo Michele Carella
Anna Locasciulli
Anna Maria Raiola
Anna Paola Iori
P304
P356
10.1016/J.BBMT.2014.03.004
P50
P577
2014-03-14T00:00:00Z